Author: Chengyang Jing1,2, Kuangshi Li2, Zongheng Li3, Yiting Sun1,2, Jiabao Wu1,2, Yingjie Li1,2, Yuyue Li1,2, Li Zhou2, Zhe Zhang2, Mingzhi Zhao2, Yong Zhang2
Affiliation: <sup>1</sup> First Clinical Medical School, Beijing University of Chinese Medicine, Beijing, China.
<sup>2</sup> Department of Rehabilitation, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.
<sup>3</sup> Department of Rehabilitation, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China lee_zongheng@163.com.
Conference/Journal: BMJ Open
Date published: 2021 May 18
Other:
Volume ID: 11 , Issue ID: 5 , Pages: e046003 , Special Notes: doi: 10.1136/bmjopen-2020-046003. , Word Count: 270
Introduction:
Acute ischaemic stroke (AIS) is not only seriously damaging to the physical and mental health of patients, but also has become a major social public health problem. Effective dyskinesia rehabilitation treatment in convalescence is of great significance for AIS patients' prognosis and quality of life. Tai Chi (TC) shows great potential in improving motor function. This trial aims to evaluate the clinical efficacy of modified TC postural training (TPT), and to explore the related central-peripheral neurotransmitter mechanisms.
Methods/design:
The proposed study will be a multicentre randomised controlled trial. The trial will randomise 120 eligible AIS patients in a 1:1 ratio to receive TPT or Bobath rehabilitation training. Each training session will last 40 min and will be implemented once a day and five times per week (from Monday to Friday) in a duration of 4 weeks. After finishing the 4-week treatment, another 3-month follow-up period will be seen. Root mean square generated from the surface electromyogram (sEMG) will be the primary outcome. Other sEMG time-domain parameters and frequency-domain parameters and clinical scales assessment will be the secondary outcomes. Peripheral blood samples will be collected at baseline and at the end of 4-week treatment, which will be used to explore the related therapeutic mechanisms. Intention-to-treat analysis and per-protocol analysis will both be implemented in this trial.
Ethics and dissemination:
The study has been approved by Ethics Committee of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, being granted approval numbers DZMEC-KY-2020-22. The research results will be disseminated through (open access) peer-reviewed publications and presentations at conferences.
Trial registration number:
ChiCTR2000032999.
Keywords: complementary medicine; rehabilitation medicine; stroke medicine.
PMID: 34006551 DOI: 10.1136/bmjopen-2020-046003